FDA Seeks Nominations for Members to Serve on the Tobacco Products Scientific Advisory Committee

August 15, 2016

FDA Seeks Nominations for Individuals to Serve on Tobacco Products Scientific Advisory Committee

On Monday, August 15th, FDA issued a notice requesting nominations for a nonvoting member to serve on the Tobacco Products Scientific Advisory Committee to represent the interests of tobacco growers.  In addition, FDA is also seeking a nominee to act as an alternate to this representative.

FDA states that any organization interested in participating in the selection of this nonvoting member should notify the Agency in writing by September 14, 2016.  The nominee may be “self-nominated or nominated by an organization to serve as a nonvoting industry representative.”

Tobacco Products Scientific Advisory Committee

The role of the Tobacco Products Scientific Advisory Committee is to guide the FDA Commissioner.  “The Committee reviews and evaluates safety, dependence, and health issues relating to tobacco products and provides appropriate advice, information, and recommendations to the Commissioner.”

Application Procedure

FDA’s notice states that nominations will only be accepted for positions that are vacant as of the publication date of the Agency’s notice.  Contact information, current curriculum vitae (CV), and the name of the committee of interest should be sent to the FDA Advisory Committee Membership Nomination Portal by September 14, 2016.

In addition, FDA states that it “seeks to include the views of women, and men, members of all racial and ethnic groups, and individuals with and without disabilities on its advisory committees and, therefore encourages nominations of appropriately qualified candidates from these groups.”

Medical Devices Agency Alerts

February 28, 2019

Draft Guidance: Requesting Nonbinding Feedback After an FDA Inspection of Your Medical Device Establishment

On Tuesday, February 19th, FDA published a draft guidance for medical device makers which identifies a process for companies to request nonbinding feedback on certain FDA Form 483 deficiencies noted...

Read the Full Article
Agency Alerts General Regulatory

September 16, 2015

FDA Takes Genomic Testing a Step Further with Regulatory Strategies & Public Workshops

FDA has announced plans to develop diagnostic systems for the use of next generation sequencing (NGS) technologies, furthering the Precision Medicine Initiative (PMI) ordered by President Obama. The...

Read the Full Article
Agency Alerts Regulatory Sciences

March 9, 2016

FDA to Review PhUSE Nonclinical Study Data Reviewer’s Guide Template

As a part of its ongoing collaboration with the Pharmaceutical Users Software Exchange (PhUSE), the FDA has announced its plans to review the proposed Nonclinical Study Data Reviewer’s Guide (SDRG)...

Read the Full Article